Media contact
Nicklas Westerholm, CEO
nicklas.westerholm@egetis.com
Yilmaz Mahshid, CFO
yilmaz.mahshid@egetis.com
Calendar and upcoming reports
April 6, 2023
Penser Podden
April 26, 2023
Interim report January-March 2023
News room
Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment
Nicklas Westerholm, CEO
nicklas.westerholm@egetis.com
Yilmaz Mahshid, CFO
yilmaz.mahshid@egetis.com
April 6, 2023
Penser Podden
April 26, 2023
Interim report January-March 2023
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: info@egetis.com
